R&D expenses grew to $1.54 billion in Q1, driven by higher clinical trial costs and hiring more R&D staff.
Filing excerpt
Research and development [expenses for three months ended March 31, 2026 were] $1,543.5 [million] [compared to] $1,327.4 [million for three months ended March 31, 2025]
What this signalsFilings often name leadership changes, deals and spending plans.
sec-10qcapexIncreaseGet every 10-Q signal for Regeneron and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Regeneron this week?”
The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/32eec79a-0fcd-48c9-8ccb-9cb22a19e322 returns this record as JSON. POST /v1/companies/enrich returns every signal for regeneron.com.
{
"signal_id": "32eec79a-0fcd-48c9-8ccb-9cb22a19e322",
"signal_type": "sec-10q",
"signal_subtype": "capexIncrease",
"detected_at": "2026-05-05T08:48:22.099+00:00",
"company": {
"name": "Regeneron",
"domain": "regeneron.com"
},
"data": {
"detail": "R&D expenses grew to $1.54 billion in Q1, driven by higher clinical trial costs and hiring more R&D staff. This signals significant investment and budget allocation for research tools, clinical trial services, and talent acquisition.",
"metrics": {
"timeframe": "current_quarter",
"dollar_context": "Quarterly research and development expense",
"dollar_millions": 1543.5
},
"summary": "Regeneron boosts R&D spend by $216M YoY, increasing headcount",
"excerpts": "Research and development [expenses for three months ended March 31, 2026 were] $1,543.5 [million] [compared to] $1,327.4 [million for three months ended March 31, 2025]",
"relevance": 0.85,
"sentiment": "positive",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/872589/000087258926000016/regn-20260331.htm",
"filing_date": "2026-04-29",
"filing_year": 2026,
"fiscal_year": 0,
"fiscal_year_end": "03/31",
"sales_relevance": "Budget available",
"signal_category": "financial"
}
}
curl https://signals.autobound.ai/v1/signals/32eec79a-0fcd-48c9-8ccb-9cb22a19e322 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"regeneron.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.